Email Alert | RSS    帮助

中国防痨杂志 ›› 2014, Vol. 36 ›› Issue (9): 793-797.doi: 10.3969/j.issn.1000-6621.2014.09.009

• 专家论坛 • 上一篇    下一篇

我国结核病病理学诊断和研究的现状与展望

张海青 车南颖   

  1. 101149  首都医科大学附属北京胸科医院 北京市结核病胸部肿瘤研究所病理科
  • 收稿日期:2014-07-08 出版日期:2014-09-10 发布日期:2014-11-28
  • 通信作者: 张海青 E-mail:zhqing56@sina.com
  • 基金资助:

    国家自然科学青年基金项目(81101332)

Current situation and prospect of pathological diagnosis and research on tuberculosis in China

ZHANG Hai-qing,CHE Nan-ying   

  1. Department of Pathology, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China
  • Received:2014-07-08 Online:2014-09-10 Published:2014-11-28
  • Contact: ZHANG Hai-qing E-mail:zhqing56@sina.com

摘要: 本文对我国结核病病理学诊断现状及分子病理学在未来结核病诊断和基础研究中的作用进行了阐述。与其他方法相比,病理学诊断依然是结核病、尤其是菌阴肺结核及肺外器官结核病确诊的重要手段。目前,我国结核病病理诊断总体上处于组织学和细胞学水平,仍以组织学形态特征和查找病原体作为结核病诊断依据。因PCR的临床检测对实验室、仪器设备及技术人员的要求较高,所以目前国内仅部分大型医院病理科开展了此项检查。分子病理学科的发展,将病理学的研究与诊断引领到蛋白、核酸等生物大分子水平,为结核病病理学诊断及研究带来了新的发展机遇。近年来,分子生物学检测技术发展迅速,在痰标本、体液标本等应用广泛,而在组织标本中推广较慢,因此,需要加快这些新技术在结核病分子病理学诊断中的临床应用。今后,结核病病理学诊断应在病理形态的基础上,进一步在寻找病原体、菌型鉴定及相关耐药基因的检测等方面做更多努力,为结核病的正确诊断与合理化治疗提供更准确的依据。

Abstract: In this paper, we reviewed current pathological diagnosis situation of tuberculosis (TB), and the roles of new molecular pathological techniques on TB diagnosis and basic research in China. Compared with other methods, pathological diagnosis has remarkable advantages in making definite diagnosis of TB cases, especially for bacteria negative pulmonary TB and extrapulmonary TB patients. Up to now, pathological diagnosis generally remains on histological and cellular level in our country, mainly focuses on histological characters and finding pathogens. TB-PCR tests are limited to a few department of pathology in large hospitals due to high requirements for laboratory, instruments and technicians. Development of the new subdiscipline molecular pathology has led pathological research and diagnosis approach into detecting biomacromolecules such as protein and nucleic acids, which brin-ging new development opportunities for pathological diagnosis and research of TB. In recent years, molecular techniques have developed rapidly and widely applied in testing sputum and body fluid samples. However, application of these new techniques on tissue samples is rather delayed and needs acceleration for clinical utilization. In future, TB pathological diagnosis should not only rely on histological changes, but also make more efforts in finding pathogens, identifying mycobacteria species, and detecting mutations of drug-resistant related genes, in order to provide more accurate evidences to improve efficiency of TB diagnosis and treatment.